Funding announcement

EPIC awards over $1 million in funding to advance innovative infectious disease research

The Emerging and Pandemic Infections Consortium is investing $1.05 million in innovative, cross-disciplinary research to tackle infectious threats and bolster preparedness against future outbreaks. The funding, awarded through the Career Transition Awards, Convergence Postdoctoral Fellowships, New Connections Grants and Proof-of-Principle Grants, will support researchers and senior trainees at the University of Toronto and partner hospitals. The 12 funded projects span a wide breadth of research topics from organ-on-a-chip models of infection to new approaches that aim to improve disease prevention, diagnosis and treatment.

read more

Landon J. Getz receives inaugural GSK EPIC Convergence Postdoctoral Fellowship in Antimicrobial Resistance

EPIC is pleased to announce Landon J. Getz as the recipient of the inaugural GSK EPIC Convergence Fellowship in Antimicrobial Resistance (AMR). Established through a generous gift from GlaxoSmithKline (GSK), the fellowship will support Getz’s innovative and cross-disciplinary research that aims to address the growing threat of AMR through the development of phage therapy.

read more

EPIC announces recipients of its inaugural Inspire Summer Studentships

The Emerging and Pandemic Infections Consortium (EPIC) has announced the four recipients of the 2023 Inspire Summer Studentships. These studentships aim to foster inclusive excellence by providing third-year Black and Indigenous undergraduate students with opportunities to engage in infectious disease research with and receive mentorship from EPIC’s faculty members. Each award provides $7,500 to support the student for a 16-week work term.

read more

EPIC announces 31 recipients of its inaugural Doctoral Awards

The Emerging and Pandemic Infections Consortium (EPIC) has announced its inaugural cohort of Doctoral Awards recipients. These 31 PhD students are engaged in innovative and collaborative research on infectious diseases. Their work spans from fundamental research uncovering the inner workings of microbes and their interactions with hosts, to applied research focused on improving diagnostics and vaccines, to community-based research on the social and economic impacts of infectious diseases.

read more

U of T home to new hub that will strengthen Canada’s pandemic preparedness and increase biomanufacturing capacity

A new national hub focused on enhancing Canada’s ability to respond quickly, effectively and equitably to future pandemics has become a reality with $2 million in funding from the Canada Biomedical Research Fund. Led and anchored by the University of Toronto, the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) is a collaborative, multi-disciplinary and multi-sector coalition of over 80 partners. It will provide a powerful network to support a robust domestic pipeline of life-saving vaccines and therapeutics targeting existing and emerging infectious threats.

read more

U of T receives $35 million to modernize high containment facility

The University of Toronto has received $35 million in critical research infrastructure funding from the federal government to revitalize the Toronto High Containment Facility (THCF), an investment that will support a planned $85-million transformation of the facility into the largest academic high-containment research centre in Canada. With significantly increased capacity for research and training, the revitalized Toronto High Containment Facility will be able to drive innovation, enhance pandemic preparedness and strengthen Ontario and Canada’s health security.

read more


Related links

Related page →

Link to resource →

Contact us CTA →